Weathering a cytokine storm with extracellular vesicles

Researchers from the University of Osaka found that hepatocyte-derived extracellular vesicles treated with sPLA2 (SPLEVs) induce a lipid counterstorm that counteracts cytokine storm in mice with acute respiratory distress syndrome. SPLEVs also demonstrated significant beneficial effects in mouse models of sepsis, coagulopathy, liver injury, colitis, and pneumonia. As lysophosphatidylglycerols were identified as a key mediator of SPLEV activity, these findings suggest a promising approach for developing inexpensive, cell-free anti-inflammatory treatments.Read More